Term
two main components of pain |
|
Definition
1. physical (acute/chronic, nociceptive/neuropathic, somatic/visceral)
2. psychological (memory, fear, anticipation, depression) |
|
|
Term
two classes of pharmacologic analgesics |
|
Definition
1. Narcotics (opioids)
2.Non-Narcotic analgesics (NSAIDs etc.) |
|
|
Term
Opioid effects on both main aspects of pain |
|
Definition
physiological threshold for pain percpetion raised
affective response (psychological reaction) altered (often producing euphoria or disphoria) |
|
|
Term
|
Definition
Thalamus
Limbic System(amygdala, hippocampus, fornix, etc.)
Brain Stem
Spinal Cord--spinothalamic tracts especially, respond to endogenous and exogenous opioids, targeted by intrathecal or epidural opioids to cause analgesia--pre-synaptic opioid receptors inhibit neurotransmitter release while post-synaptic opioid receptors inhibit AP propagation |
|
|
Term
|
Definition
enkephalins (from proenkephalins)
endorphins (from pro-opiomelanocortin POMC)
dynorphins (from prodynorphin)
peptide neurotransmitters, same properties as exogenous opioids (analgesic effects, blocked by naloxone, act on opioid receptors in CNS)
basis for pain releif using acupuncture |
|
|
Term
|
Definition
7 transmembrane domain G protein coupled receptors (GPCRs)
distributions of subtypes vary throughout CNS
mu (most important for analgesia)
kappa (prevalent in spinal cord)
delta
sigma (not a true opioid receptor though some opioids cross react with sigma receptors) |
|
|
Term
|
Definition
most important for pain control
binds morphine
GPCR which when stimulated may produce analgesia, euphoria, sedation, physical and psychological dependence, respiratory depression (hypoxia) |
|
|
Term
|
Definition
widely distributed in spinal cord
GPCR which when stimulated may produce dysphoria (opposite of euphoria), analgesia, and sedation |
|
|
Term
|
Definition
prototypic exogenous opioid derived from poppies or synthesized in labs
full mu receptor agonist--binds domains of receptor embedded in plasma membrane in addition to the N terminal binding site for endogenous opioids
maximum analgesic effect
euphoria, nausea/vomiting, mental clouding, antitussive, bronchoconstriction, respiratory depression, miosis, urinary retention, gonadotropin release inhibition, vascular dilation (orthostatic hypotension), constipative/antidiarrheal
low oral bioavailability
active metabolite (analgesic and possibly nephrotoxic action)=morphine-6-glucuronide, excreted in urine (primary method of elimination)
induces tolerance (cross tolerance w/other opioids) and physical dependance, high abuse potential
withdrawl/abstinence syndrome possible
low lipid solubiliby (hard to cross BBB)
|
|
|
Term
|
Definition
progressively higher doses required to achieve same effect
most opioid have complete or incomplete cross-tolerance with other opioids
tolerance to opioids is always pharmacodynamic (receptors downregulated or endocytosed in presence of drug) NOT metabolic (induction of liver CYPs etc.) |
|
|
Term
|
Definition
patient undergoes withdrawl/abstinence syndrome when opioid is removed from system or blocked (naloxone induces withdrawl in an opioid dependent person)
develops during long-term opioid use
not equivalent to addiction
|
|
|
Term
Adverse effects of Opioids |
|
Definition
respiratory depression (especially in opioid niaive pts!)
constipation (decreased peristalsis)
nausea & vomiting (stimulation of chemorecptor trigger zone)
abuse potential (euphoria, dependence, tolerance)
confusion/lethargy/apathy/sedation
bronchoconstriction (directly and indirectly via histamine release, especially morphine)
miosis
urinary retention (increased ADH release & direct action on bladder destrusor muscle)
hormonal disturbances (inhibits gonadotropin release)
orthostatic hypotension (histamine release, depressed adrenergic and vasomotor tone)
|
|
|
Term
Clinical uses for opioids |
|
Definition
Analgesia--typically for moderate or severe pain levels
Antitussive (rare use these days)
Antidiarrheal |
|
|
Term
|
Definition
1.miosis
2.respiratory depression
3.coma
treat immediately with Naloxone=Narcan (opioid receptor antagonist) until triad of symptoms reverses
|
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
Euphoria (most common change)
Dysphoria also possible (especially kappa agonists) |
|
|
Term
Opioid stimulated Nausea and Vomiting |
|
Definition
Chemoreceptor trigger zone irritation |
|
|
Term
Respiratory Depression caused by Opioids |
|
Definition
opioids decrease brainstem response to CO2 levels (the central drive to breathe)
bronchoconstriction: direct action on smooth muscle cell recpetors
some opioids like morphine also cause histamine release
cough reflex suppression--may be beneficial (antitussive) or harmful (airway obstructing) but typically occurs at doses below analgesic threshold |
|
|
Term
|
Definition
pinpoint pupil
common sign of overdose |
|
|
Term
Urinary Retention caused by Opioids |
|
Definition
increased ADH release from pituitary-->water reabsorption from colleting ducts in kidneys
direct inhibitory action on detrusor muscle of bladder |
|
|
Term
Hormonal effects of Opioids |
|
Definition
decreased release of LH and FSH
may disrupt fertility in males and females (transient)
menstrual irregularities in females |
|
|
Term
Cardiovascular effects of Opioids |
|
Definition
peripheral vascular dilation-->postural hypotension
caused by histamine release and depressed adrenergic tone |
|
|
Term
Metabolism and Excretion of Morphine |
|
Definition
Metabolism: glucuronide conjugation in liver
Excretion: as glucuronide via the urine |
|
|
Term
Opioid abstinence or withdrawl sydrome |
|
Definition
begins 8-12 hours after last morphine dose and peaks at 36-72 hours (varies with half-life for other opioids)
delayed onset and less severe for long acting opioids
diarrhea, vomiting, chills, fever, lacrimation, rhinorrhea, tremor, kicking/twitching
naloxone to induce (test for heroin addiction or physical depedence to any opioid)
clonidine to treat |
|
|
Term
|
Definition
centrally active alpha 2 receptor agonist
decreases norepinephrine release in brain
used to treat symptoms of opioid withdrawl |
|
|
Term
|
Definition
orally active opioid analgesic w/approximately 1/10th potency of morphine
used for mild-moderate pain, often in combo. with aspirin, acetaminophen, or NSAIDs
antitussant activity
better lipid solubility vs. morphine--crosses BBB
metabolized by CYP2D6 (pharmacogenetics:poor metabolizers get little effect) |
|
|
Term
|
Definition
opioid drug (diacetylmorphine)
variable oral absorption, parenteral absorption better
high lipid solubility--crosses BBB
IV illicit drug in the U.S.; used medically in some countries |
|
|
Term
|
Definition
opioid analgesic with similar potency and efficacy as morphine
but with higher oral availability
used for severe pain
frequently abused--addicts grind this up for a faster high
found in Oxycontin, Percocet (w/acetaminophen), and Percodan (w/aspirin)
|
|
|
Term
|
Definition
opioid analgesic with efficacy comparable to morphine but ten times more potent
for severe pain
high oral bioavailability
high abuse potential
(Dilaudid)
|
|
|
Term
|
Definition
opioid with LITTLE ANALGESIC ACTIVITY
primary use as an EMETOGENIC agent--stimulates vomiting by irritating the CTZ
can still cause respiratory depression like most opioids (titrate carefully and watch patient closely) |
|
|
Term
|
Definition
opioid with very LITTLE ANALGESIC ACTION
mainly used as an ANTITUSSANT
low addiction potential
less drowsiness and GI upset vs. codeine
a.k.a. Romilar
|
|
|
Term
|
Definition
a.k.a. Demerol
short-acting opioid analgesic
synthetic, orally active, for moderate-severe pain
1/10 the potency of morphine
popular for pain relief for women in labor
according to ICM becoming less popular in hospitals due to side effects (seizures + common opioid adverse effects)
|
|
|
Term
|
Definition
a.k.a Sublimaze
synthetic opioid analgesic 80X the potency of morphine
short-acting, t1/2 only 20 minutes
highly lipid soluble, crosses BBB, action terminated mainly by resdistribution between body compartments (like thiopental)
oral, sublingual, or IV
for severe pain, anesthetic induction, may be sole anesthetic in cardiac surgery, also used as an antipsychotic (neuroleptic) in combo. w/droperidol=innovar
|
|
|
Term
|
Definition
short-acting synthetic opioid analgesic/anesthetic similar to fentanyl
causes pain releif and muscle relaxation--good for outpatient surgery |
|
|
Term
|
Definition
a.k.a. Sufenta
short-acting synthetic opioid analgesic/anesthetic similar to fentanyl
causes pain releif and muscle relaxation--good for outpatient surgery |
|
|
Term
|
Definition
a.k.a. Dolophine
orally active synthetic opioid analgesic w/action and potency comparable to morphine
long-acting, t1/2 is about 15 hours
used for chronic pain and to treat opioid addiction (methadone maintenance)
causes less euphoria than the commonly abused opioids (heroin, morphine, oxycodone, etc.) but prevents withdrawl in addicts |
|
|
Term
LAAM (L-alpha-acetyl-methadol) |
|
Definition
a.k.a. Orlaam
long-acting sythetic orally active opioid analgesic (mu agonist)
methadone cogener used for heroin addiction treatment (reduces craving) |
|
|
Term
|
Definition
a.k.a Darvon
orally active synthetic opioid analgesic comparable to codeine in potency and use
for mild-moderate pain
usually combined with aspirin or acetaminophen |
|
|
Term
|
Definition
combined with atropine to form Lomotil
oral synthetic opioid used as an ANTI-DIARRHEAL
NOT for analgesia
some abuse potential--offset by coformulation with atropine (unpleasant antimuscarinic effects at high doses) |
|
|
Term
|
Definition
a.k.a. Immodium
OTC oral opioid drug used as an ANTIDIARRHEAL
poorly absorbed from GI tract, acts directly on intestinal musculature to inhibit motility
NOT an analgesic
low penetrantion to CNS--reduced abuse potential compared to diphenoxylate though equally effective in countering diarrhea |
|
|
Term
Treatment of Opioid Overdose |
|
Definition
(CNS depression/coma, repiratory depression, miosis)
1.Restore respiration, estabilish airway if necessary, give supplemental but not pure O2 (CO2 stimulates the stunned central respiratory center)
2.Give Naloxone (antagonist at all opioid receptors) 4-8 mg IV or IM until symptoms reverse
3.Observe patient closely and readminister naloxone as needed (shorter half life vs. most opioid drugs) |
|
|
Term
Classes of Drugs that interact Additively with Opioids to cause CNS or Respiratory Depression |
|
Definition
Sedatives
Sedative-hypnotics
Ethanol
Monoamine Oxidase Inhibitors (MAOIs)
Tricyclic antidepressants
Tranquilizers |
|
|
Term
|
Definition
Naloxone and Naltrexone
block all effects of opioids (analgesia, euphoria/dysphoria, respiratory depression, GI upset/constipation, etc.)
used to treat opioid overdose, diagnose physical dependence on opioids esp. in context of addiction, control compulsive use in addiction treatment |
|
|
Term
|
Definition
a.k.a. Narcan
short-acting pure opioid antagonist, IV or IM
competative antagonism of all opioids (including the endogenous ones) at all opioid receptors (mu, kappa, delta)
t1/2 of 1-4 hours (monitor overdose patients!)
used to treat opioid OD, may trigger withdrawl--use to diagnose dependence |
|
|
Term
|
Definition
a.k.a. Trexan
long-acting competative opioid antagonist, t 1/2 is about 24 hours, oral drug
blocks endogenous and exogenous opioid action
used to decrease cravings in programs for heroin and alcohol addiction (reduces compulsive use by eliminating endogenous opioid rush associated with alcohol abuse)
used to diagnose physical dependence on opioids--precipitates withdrawl syndrome
not as good as naloxone for emergency treatment of opioid OD b/c long-acting/slow |
|
|
Term
|
Definition
a.k.a. Talwin
mixed opioid agonist/antagonist used for analgesia in mild-moderate pain
kappa agonist--effective spinal analgesia
weak mu ANTagonist--counters morphine analgesia (but not respiratory depression) and induces withdrawl in the morphine-dependent
less severe respiratory depression and withdrawl syndrome vs. morphine
dysphoria and hallucinations at higher doses (from cross-stim. of sigma "not-an-opioid-receptor" receptors) |
|
|
Term
|
Definition
a.k.a. Nubain
kappa opioid receptor agonist
mu opioid receptor ANTagonist--induces morphine withdrawl
analgesic for moderate to severe pain with limited respiratory depression and low risk of mild dependence
low incidence of psychotomimetic effects (dysphoria/hallucinations) b/c does not stim. sigma R's
|
|
|
Term
|
Definition
a.k.a Stadol
similar to Nalbuphine
kappa opioid receptor agonist
mu opioid receptor ANTagonist--induces morphine withdrawl
analgesic for moderate to severe pain with limited respiratory depression and low risk of mild dependence
low incidence of psychotomimetic effects (dysphoria/hallucinations) b/c does not stim. sigma R's
|
|
|
Term
|
Definition
a.k.a. Buprenex
mixed mu opioid receptor agonist/antagonist
kappa ANTagonist
analgesic for moderate-severe pain
slow onset, long-lasting
lower risk of repiratory depression and withdrawl syndrome vs. morphine (still causes euphoria and miosis though)
induces withdrawl in people severely dependent on morphine
may be alternative to methadone as maintenance drug tx for opioid addicts (reduces craving)
|
|
|